English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Book Chapter

Biochemical properties of Ha-Ras encoded P21 mutants

MPS-Authors
/persons/resource/persons197471

John,  Jacob
Emeritus Group Biophysics, Max Planck Institute for Medical Research, Max Planck Society;

/persons/resource/persons282169

Frech,  Mathias
Emeritus Group Biophysics, Max Planck Institute for Medical Research, Max Planck Society;

/persons/resource/persons248639

Feuerstein,  Jürgen
Emeritus Group Biophysics, Max Planck Institute for Medical Research, Max Planck Society;

/persons/resource/persons93142

Goody,  Roger S.
Emeritus Group Biophysics, Max Planck Institute for Medical Research, Max Planck Society;

/persons/resource/persons95966

Wittinghofer,  Fred
Emeritus Group Biophysics, Max Planck Institute for Medical Research, Max Planck Society;

Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

John, J., Frech, M., Feuerstein, J., Goody, R. S., & Wittinghofer, F. (1989). Biochemical properties of Ha-Ras encoded P21 mutants. In The Guanine — Nucleotide Binding Proteins (pp. 209-214). New York, NY: Springer.


Cite as: https://hdl.handle.net/21.11116/0000-000B-564E-E
Abstract
Mutations of the ras proto-oncogenes rasH, rasK and rasN have been found in many human tumours and in the ras genes of the acutely transforming animal retroviruses HaMuSV and KiMuSV. (for reviews see Gibbs et al., 1985; Barbacid, 1987). These mutations were found to be single or double point mutations and could be localized in all cases to two different regions of the amino acid sequence of the ras encoded p21 proteins. Thus, either amino acids 12/13 or amino acids 59/61 were found to be mutated. The retroviral p21 proteins of the Kirsten and Harvey strain of MuSV contain a double mutation involving glycine12 and alanines59, where alanine59 is changed to threonine in both cases (Dhar et al., 1982; Tsuchida et al., 1982; Yasuda et al., 1984).